GNLX
Price
$2.92
Change
-$0.00 (-0.00%)
Updated
Jun 23, 04:59 PM (EDT)
Capitalization
130.93M
56 days until earnings call
Intraday BUY SELL Signals
IKT
Price
$1.88
Change
+$0.04 (+2.17%)
Updated
Jun 23, 04:09 PM (EDT)
Capitalization
243.6M
55 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

GNLX vs IKT

GNLX vs IKT Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
GNLX vs. IKT commentary
Jun 24, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GNLX is a StrongBuy and IKT is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 24, 2026
Stock price -- (GNLX: $2.92 vs. IKT: $1.85)
Brand notoriety: GNLX and IKT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GNLX: 145% vs. IKT: 79%
Market capitalization -- GNLX: $130.93M vs. IKT: $243.6M
GNLX [@Biotechnology] is valued at $130.93M. IKT’s [@Biotechnology] market capitalization is $243.6M. The market cap for tickers in the [@Biotechnology] industry ranges from $118.47B to $0. The average market capitalization across the [@Biotechnology] industry is $2B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GNLX’s FA Score shows that 0 FA rating(s) are green whileIKT’s FA Score has 0 green FA rating(s).

  • GNLX’s FA Score: 0 green, 5 red.
  • IKT’s FA Score: 0 green, 5 red.
According to our system of comparison, IKT is a better buy in the long-term than GNLX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GNLX’s TA Score shows that 2 TA indicator(s) are bullish while IKT’s TA Score has 4 bullish TA indicator(s).

  • GNLX’s TA Score: 2 bullish, 4 bearish.
  • IKT’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, IKT is a better buy in the short-term than GNLX.

Price Growth

GNLX (@Biotechnology) experienced а -3.31% price change this week, while IKT (@Biotechnology) price change was +10.48% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.89%. For the same industry, the average monthly price growth was +2.09%, and the average quarterly price growth was +1952.22%.

Reported Earning Dates

GNLX is expected to report earnings on Aug 18, 2026.

IKT is expected to report earnings on Aug 17, 2026.

Industries' Descriptions

@Biotechnology (+5.89% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IKT($244M) has a higher market cap than GNLX($131M). IKT YTD gains are higher at: -10.000 vs. GNLX (-33.028). GNLX has higher annual earnings (EBITDA): -34.04M vs. IKT (-55.75M). IKT has more cash in the bank: 170M vs. GNLX (26.2M). IKT has less debt than GNLX: IKT (0) vs GNLX (2.5M). GNLX has higher revenues than IKT: GNLX (8K) vs IKT (0).
GNLXIKTGNLX / IKT
Capitalization131M244M54%
EBITDA-34.04M-55.75M61%
Gain YTD-33.028-10.000330%
P/E RatioN/A3.47-
Revenue8K0-
Total Cash26.2M170M15%
Total Debt2.5M0-
TECHNICAL ANALYSIS
Technical Analysis
GNLXIKT
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
86%
MACD
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 8 days ago
90%
Bullish Trend 2 days ago
84%
Declines
ODDS (%)
Bearish Trend 22 days ago
86%
Bearish Trend 16 days ago
90%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
GNLX
Daily Signal:
Gain/Loss:
IKT
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
USIFX34.58N/A
N/A
Victory International
FEMMX62.27N/A
N/A
Fidelity Advisor Emerging Markets C
LICSX21.75N/A
N/A
Lord Abbett International Equity R4
RMYAX10.54N/A
N/A
Russell Inv Multi-Strategy Income A
PQDMX18.53N/A
N/A
PGIM Quant Solutions Intl Dev Mkts IdxR6

IKT and

Correlation & Price change

A.I.dvisor tells us that IKT and VYGR have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IKT and VYGR's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IKT
1D Price
Change %
IKT100%
+0.82%
VYGR - IKT
32%
Poorly correlated
N/A
BNTC - IKT
31%
Poorly correlated
+1.23%
GNLX - IKT
31%
Poorly correlated
-1.52%
ZLAB - IKT
31%
Poorly correlated
+1.65%
VIR - IKT
31%
Poorly correlated
+4.48%
More